🇺🇸 FDA

Intelligence · Clinical Pipeline

R&D Pipeline Programs

ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.

Programs indexed
20,548
Companies
1,769
Drugs tracked
4,797

Quick answer

NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.

1,413 results for “Chinese” Clear

  1. Low Density Lipoprotein Receptor mRNA Exosomes

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Familial Hypercholesterolemia

    phase 1 mab active

    1 trial

  2. Low Dose MSH2-/- tumor cell vaccine

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    pMMR/MSS Advanced Colorectal Cancer

    phase 1 mab active

    1 trial

  3. Low Level Laser Therapy

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Orthodontic Appliance Complication

    phase 1 other completed

    1 trial

  4. Lysogenic HSV virus.

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    HNSCC

    phase 1 mab active

    1 trial

  5. MSCs

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    COVID-19

    phase 1 mab active

    1 trial

  6. MSCs-derived exosomes

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Coronavirus

    phase 1 mab completed

    1 trial

  7. MWN109 tablet

    Shanghai University of Traditional Chinese Medicine

    Overweight or Obesity

    phase 1 small molecule active

    1 trial

  8. Macitentan 10 mg tablet, once daily.

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Coronary Microvascular Angina

    phase 1 small molecule active

    1 trial

  9. Mesenchymal Stem Cell Infusion

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Immune Effector Cell Associated Hematotoxicity

    phase 1 mab active

    1 trial

  10. Methosulide

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Healthy

    phase 1 small molecule completed

    1 trial

  11. Methylene Blue (50 mg/10ml)

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Head and Neck Cancer

    phase 1 small molecule active

    1 trial

  12. Midazolam

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Delirium

    phase 1 small molecule active

    1 trial

  13. Misoprostol

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Hypotonic; Labor

    phase 1 small molecule completed

    1 trial

  14. Modified Gegen Qinlian Decoction

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Ulcerative Colitis

    phase 1 small molecule active

    1 trial

  15. Mudan granule

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Diabetic Peripheral Neuropathy Type 2

    phase 1 small molecule active

    1 trial

  16. NK510

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    NSCLC

    phase 1 small molecule active

    1 trial

  17. NeuroRegen scaffold with BMMCs or MSCs transplantation

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Spinal Cord Injury

    phase 1 mab active

    1 trial

  18. Nicorette Extra Mint 2 mg Gum

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Tobacco Dependence

    phase 1 small molecule completed

    1 trial

  19. Nivolumab

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Effect of Drug

    phase 1 small molecule active

    1 trial

  20. Octreotide

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Enterocutaneous Fistulas

    phase 1 small molecule completed

    1 trial

  21. Olfactory ensheathing cells

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Infarction, Middle Cerebral Artery

    phase 1 other active

    1 trial

  22. Olverembatinib, APG-2575, Dexamethasone

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Lymphoblastic Leukemia, Acute, Childhood

    phase 1 small molecule active

    1 trial

  23. Omega 3 fatty acid

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Male Infertility Due to Hypospermatogenesis

    phase 1 small molecule active

    1 trial

  24. Oncolytic Virus SDJ001

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Malignant Tumor

    phase 1 small molecule active

    1 trial

Frequently asked questions

What is the NovaPharmaNews pipeline directory?

It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.

Where does pipeline data come from?

Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.

How do I find pipeline programs by company or phase?

Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.

Data attribution and licensing: Data sources